ALSO READAbbott India Q1 net profit down 35% at Rs 48 crore Abbott India soars 20% on strong Q2 results NPPA allows Abbott to discontinue bioresorbable stent over safety concerns Abbott to discontinue sales of fully biodegradable stent Govt bars Abbott from withdrawing stent to maintain uninterrupted supply
Drug firm Abbott India today reported 83.31 per cent jump in net profit to Rs 137.52 crore for the September quarter on account of robust sales.
It had posted a net profit of Rs 75.02 crore for the corresponding period of last fiscal, Abbott India said in a filing to BSE.
The total income of the company also rose to Rs 946.04 crore for the July-September quarter of 2017-18 as against Rs 743.78 crore in the same quarter of 2016-17.
The Abbott India stock was trading at Rs 5,170 on BSE, up about 15 per cent, on BSE.